Pathogenesis of cancers derived from thyroid follicular cells

JA Fagin, GP Krishnamoorthy, I Landa - Nature reviews Cancer, 2023 - nature.com
The genomic simplicity of differentiated cancers derived from thyroid follicular cells offers
unique insights into how oncogenic drivers impact tumour phenotype. Essentially, the main …

The current histologic classification of thyroid cancer

SL Asa - Endocrinology and Metabolism Clinics, 2019 - endo.theclinics.com
The Current Histologic Classification of Thyroid Cancer - Endocrinology and Metabolism
Clinics Skip to Main Content Skip to Main Menu Advertisement Endocrinology and …

[图书][B] Thyroid cancer: a comprehensive guide to clinical management

L Wartofsky, D Van Nostrand - 2006 - Springer
are new to this edition. The authors provide not only the The second edition of Thyroid
Cancer: A Comp-most current review of their respective areas, but also their hensive Guide …

Poorly differentiated thyroid carcinoma

B Xu, R Ghossein - Seminars in Diagnostic Pathology, 2020 - Elsevier
Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of follicular cell derived
thyroid carcinoma with a prognosis intermediate between the indolent well differentiated …

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance

G Acquaviva, M Visani, A Repaci, KJ Rhoden… - …, 2018 - Wiley Online Library
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …

Evolving approaches to patients with advanced differentiated thyroid cancer

BR Haugen, SI Sherman - Endocrine reviews, 2013 - academic.oup.com
Advanced differentiated thyroid cancer (DTC), defined by clinical characteristics including
gross extrathyroidal invasion, distant metastases, radioiodine (RAI) resistance, and avidity …

Molecular genetics of follicular-derived thyroid cancer

E Macerola, AM Poma, P Vignali, A Basolo, C Ugolini… - Cancers, 2021 - mdpi.com
Simple Summary Thyroid tumors that derive from follicular cells are not a homogeneous
entity, showing variable morphological appearance and different degrees of differentiation …

[HTML][HTML] Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities

L Zhang, Q Feng, J Wang, Z Tan, Q Li, M Ge - Biochimica et Biophysica …, 2023 - Elsevier
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery,
chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC …

[HTML][HTML] Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma

H Teng, F Mao, J Liang, M Xue, W Wei, X Li… - Theranostics, 2018 - ncbi.nlm.nih.gov
Papillary thyroid carcinoma (PTC) is the fastest-growing disease caused by numerous
molecular alterations in addition to previously reported DNA mutations. There is a …

Thyroid cancers: from surgery to current and future systemic therapies through their molecular identities

L Lorusso, V Cappagli, L Valerio, C Giani… - International Journal of …, 2021 - mdpi.com
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …